Search fresh public links, source activity, and post angles for Aacr 2026.
Fresh curated links around AACR 2026 are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed. The post AACR 2026: where is cancer therapeutics heading? appeared...
Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung tumors.
Patient advocates from the AACR Scientist↔Survivor Program shared their research on cancer during the AACR Annual Meeting 2026. The post A Shared Path Toward Cancer Progress appea...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to be priorities. The post Anthony Letai, MD, PhD, FAACR,...
Live updates from the fifth day of the AACR Annual Meeting 2026, including a plenary on early-onset cancers, the final Clinical Trial Plenary, and more. The post Live Updates From...
A recap of the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and overall meeting highlights. The post Daily Recaps From the AACR...
Live updates from throughout the first day of the AACR Annual Meeting 2026, including educational sessions and other highlights. The post Live Updates From the AACR Annual Meeting...
Before heading to the AACR meeting in San Diego, program chairs Paul Mischel and Alice Shaw shared insights with GEN on the key themes shaping this year’s program and what excites...
Live updates from the fourth day of the AACR Annual Meeting 2026, including a plenary on AI, the NCI Director’s Address, and more. The post Live Updates From the AACR Annual Meetin...
Live updates from the second day of the AACR Annual Meeting 2026, including the 5K, clinical trials, Discovery Science Plenary, and more. The post Live Updates From the AACR Annual...
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research (AACR) Annual Meeting in 2026, he...
Live updates from the third day of the AACR Annual Meeting 2026, including the Opening Plenary, Clinical Trial Plenaries, and more. The post Live Updates From the AACR Annual Meeti...
From the AACR Annual Meeting in San Diego, Julianna LeMieux and Damian Doherty report on early highlights, including key insights and takeaways from the first few days of the meeti...
The latest edition of our "From the Bench" series examines creative research approaches presented at the AACR Annual Meeting 2026 enabling new insights into cancer. The post From t...
AACR's annual awards recognize scientific contributions in basic, translational, clinical, and epidemiological cancer research. Recipients are laboratory researchers, physician-sci...
A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics, and more. The post How Does the Most Important Cancer...
A few AACR Runners for Research shared their thoughts as they prepare to pound some pavement and raise money at the AACR Annual Meeting 2026. The post Five Kilometers, 3.11 Miles,...
From organoid models to pathology, AI is increasingly embedded across cancer research areas. Fay Lin, PhD, and Jonathan D. Grinstein, PhD, discuss how challenges, such as adoption...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic cancer, and more. The post FDA Approvals in Oncology: Ja...
By AACR Associate Member Council members, 2025-2026 Attending the AACR Annual Meeting is a defining moment for early‑career researchers in the field of cancer research. The meeting...
Ultima Genomics will present ppmSeq MRD data at the AACR Annual Meeting, including TRACERx study findings, demonstrating ultra-sensitive whole-genome ctDNA detection at parts-per-m...
Domain-adaptive foundation model bridges clinical and preclinical cancer biology across 130,000+ oncology samples
Path-IO accurately stratified immunotherapy outcomes for patients with metastatic non-small cell lung cancer (NSCLC). The model is validated across international real-world cohorts...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.